Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results

COATES L., Mease P., Kronbergs A., Helt C., Sandoval D., Park SY., Combe B., Nash P., Deodhar A.

Type

Journal article

Journal

Clinical rheumatology

Publisher

Springer Verlag

Publication Date

18/05/2022

Permalink